The purpose of this research study is to find out what Coloradans think about COVID-19 treatments. We also want to learn how to help people get new treatments for COVID-19. Compensation provided.
We are interested in learning about your perspectives on the use of mAb treatment for COVID-19, which have recently received Emergency Use Authorization from the FDA. We are also interested in your experiences referring patients at high risk for poor outcomes from COVID-19 to receive MAbs treatment. Compensation provided.
This project is funded by a grant from the National Institutes of Health (NIH) and National Center for Advancing Translational Sciences (NCATS) (award number UL1-TR002535-03S3).